ASCI 2010 contrast media guideline for cardiac imaging: A report of the Asian Society of Cardiovascular Imaging cardiac computed tomography and cardiac magnetic resonance imaging guideline working group

International Journal of Cardiovascular Imaging

Volumn 26, Issue SUPPL. 2, 2010, Pages 203-212

  Jinzaki, Masahiro ^a   Kitagawa, Kakuya ^b   Tsai, I Chen ^c   Chan, Carmen ^d   Yu, Wei ^e   Yong, Hwan Seok ^f   Choi, Byoung Wook ^g  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^d QUEEN MARY HOSPITAL   (Hong Kong)

^e CAPITAL MEDICAL UNIVERSITY   (China)

^f Korea University College of Medicine   (South Korea)

^g Yonsei University College of Medicine   (South Korea)

Author keywords

Adverse effect; Contrast media; Injection protocol

Indexed keywords

ACETYLCYSTEINE; BICARBONATE; CONTRAST MEDIUM; GADOLINIUM; IODINATED CONTRAST MEDIUM; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT;

ARTICLE; BRONCHOSPASM; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONSERVATIVE TREATMENT; CONTRAST INDUCED NEPHROPATHY; CONTRAST MEDIUM EXTRAVASATION; CONVULSION; DIAPHORESIS; DROWSINESS; FACE EDEMA; FAINTNESS; GLOMERULUS FILTRATION RATE; HEADACHE; HEART ARREST; HIGH RISK PATIENT; HUMAN; HYPOTENSION; LARYNX EDEMA; LUNG EDEMA; NAUSEA; NEPHROGENIC SYSTEMIC FIBROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT ASSESSMENT; PATIENT SELECTION; PRACTICE GUIDELINE; PRURITUS; RASH; RESPIRATORY ARREST; RISK FACTOR; RISK REDUCTION; SIDE EFFECT; SKIN MANIFESTATION; THYROTOXICOSIS; URTICARIA; VOMITING;

ASIA; ASIAN CONTINENTAL ANCESTRY GROUP; CARDIOVASCULAR DISEASES; CONTRAST MEDIA; HEALTH CARE SURVEYS; HUMANS; MAGNETIC RESONANCE IMAGING; PREDICTIVE VALUE OF TESTS; QUESTIONNAIRES; RISK ASSESSMENT; RISK FACTORS; SOCIETIES, MEDICAL; TOMOGRAPHY, X-RAY COMPUTED;

EID: 78650511346     PISSN: 15695794     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10554-010-9691-3     Document Type: Article

References (55)

1. American College of Radiology Manual on Contrast Media v7 http://www.acr.org/SecondaryMainMenuCategories/quality-safety/contrast-manual. aspx
2. ESUR Guidelines on Contrast media (2006) Ver 6.0 http://www.esur.org/ fileadmin/Guidelines/ESUR-2007-Guideline-6-Kern-Ubersicht.pdf
3. S Matsuo E Imai M Horio, et al. 2009 Revised equations for estimated GFR from serum creatinine in Japan Am J Kidney Dis 53 6 982 992 1:CAS:528: DC%2BD1MXnslKku7c%3D 10.1053/j.ajkd.2008.12.034 19339088
4. Y Ma L Zuo JH Chen, et al. 2006 Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease J Am Soc Nephrol 17 10 2937 2944 10.1681/ASN.2006040368 16988059
5. D Fleischmann A Kamaya 2009 Optimal vascular and parenchymal contrast enhancement: the current state of the art Radiol Clin North Am 47 1 13 26 10.1016/j.rcl.2008.10.009 19195531
6. KT Bae JP Heiken JA Brink 1998 Aortic and hepatic peak enhancement at CT: effect of contrast medium injection rate-pharmacokinetic analysis and experimental porcine model Radiology 206 2 455 464 1:STN:280: DyaK1c7hvVCjtg%3D%3D 9457200
7. F Cademartiri A van der Lugt G Luccichenti, et al. 2002 Parameters affecting bolus geometry in CTA: a review J Comput Assist Tomogr 26 4 598 607 10.1097/00004728-200207000-00022 12218827
8. CR Becker C Hong A Knez, et al. 2003 Optimal contrast application for cardiac 4-detector-row computed tomography Invest Radiol 38 11 690 694 10.1097/01.rli.0000084886.44676.e4 14566178
9. F Cademartiri NR Mollet PA Lemos, et al. 2006 Higher intracoronary attenuation improves diagnostic accuracy in MDCT coronary angiography AJR Am J Roentgenol 187 4 W430 W433 10.2214/AJR.05.1406 16985117
10. F Cademartiri E Maffei AA Palumbo, et al. 2008 Influence of intra-coronary enhancement on diagnostic accuracy with 64-slice CT coronary angiography Eur Radiol 18 3 576 583 10.1007/s00330-007-0773-0 17934740
11. F Cademartiri NR Mollet A van der Lugt, et al. 2005 Intravenous contrast material administration at helical 16-detector row CT coronary angiography: effect of iodine concentration on vascular attenuation Radiology 236 2 661 665 10.1148/radiol.2362040468 16040923
12. C Rist K Nikolaou MA Kirchin, et al. 2006 Contrast bolus optimization for cardiac 16-slice computed tomography: comparison of contrast medium formulations containing 300 and 400 milligrams of iodine per milliliter Invest Radiol 41 5 460 467 10.1097/01.rli.0000208239.34723.5d 16625109
13. D Fleischmann GD Rubin AA Bankier, et al. 2000 Improved uniformity of aortic enhancement with customized contrast medium injection protocols at CT angiography Radiology 214 2 363 371 1:STN:280:DC%2BD3c7jvVKmsg%3D%3D 10671582
14. P Haage T Schmitz-Rode D Hübner, et al. 2000 Reduction of contrast material dose and artifacts by a saline flush using a double power injector in helical CT of the thorax AJR Am J Roentgenol 174 4 1049 1053 1:STN:280:DC%2BD3c3htVyjtA%3D%3D 10749248
15. F Tatsugami T Kanamoto G Nakai, et al. 2010 Reduction of the total injection volume of contrast material with a short injection duration in 64-detector row CT coronary angiography Br J Radiol 83 985 35 39 1:STN:280:DC%2BC3c%2FovFCrtA%3D%3D 10.1259/bjr/23203690 19505968
16. F Tatsugami M Matsuki Y Inada, et al. 2010 Feasibility of low-volume injections of contrast material with a body weight-adapted iodine-dose protocol in 320-detector row coronary CT angiography Acad Radiol 17 2 207 211 10.1016/j.acra.2009.09.010 19926497
17. LM Mitsumori E Wang JM May, et al. 2010 Triphasic contrast bolus for whole-chest ECG-gated 64-MDCT of patients with nonspecific chest pain: evaluation of arterial enhancement and streak artifact AJR Am J Roentgenol 194 3 W263 W271 10.2214/AJR.09.2788 20173125
18. D Litmanovich GA Zamboni TH Hauser, et al. 2008 ECG-gated chest CT angiography with 64-MDCT and tri-phasic IV contrast administration regimen in patients with acute non-specific chest pain Eur Radiol 18 2 308 317 10.1007/s00330-007-0739-2 17763855
19. Lu JG, Lv B, Chen XB et al. (2009) What is the best contrast injection protocol for 64-row multi-detector cardiac computed tomography? Eur J Radiol [Epub ahead of print]
20. Lee VS (2006) Cardiovascular MR imaging: physical principles to practical protocols. In: Lee VS (ed) Tissue characteristics and contrast agents: PD, T1 and T2, 1st edn. Lippincott Williams & Wilkins, Philadelphia, pp 42-50
21. M Ishida H Sakuma S Murashima, et al. 2009 Absolute blood contrast concentration and blood signal saturation on myocardial perfusion MRI: estimation from CT data J Magn Reson Imag 29 1 205 210 10.1002/jmri.21470
22. JA Webb HS Thomsen SK Morcos 2005 Members of Contrast Media Safety Committee of European Society of Urogenital Radiology (ESUR). The use of iodinated and gadolinium contrast media during pregnancy and lactation Eur Radiol 15 6 1234 1240 10.1007/s00330-004-2583-y 15609057
23. H Sakuma Y Ichikawa S Chino, et al. 2006 Detection of coronary artery stenosis with whole-heart coronary magnetic resonance angiography J Am Coll Cardiol 48 10 1946 1950 10.1016/j.jacc.2006.07.055 17112982
24. K Yamaguchi H Katayama T Takashima, et al. 1991 Prediction of severe adverse reactions to ionic and nonionic contrast media in Japan: evaluation of pretesting. A report from the Japanese Committee on the Safety of Contrast Media Radiology 178 2 363 367 1:STN:280:DyaK3M7gt1agtw%3D%3D 1987594
25. D Laroche I Aimone-Gastin F Dubois, et al. 1998 Mechanisms of severe, immediate reactions to iodinated contrast material Radiology 209 1 183 190 1:STN:280:DyaK1cvktF2ltA%3D%3D 9769830
26. KD Hopper PS Houts TR TenHave, et al. 1994 The effect of informed consent on the level of anxiety in patients given i.v. contrast material AJR Am J Roentgenol 162 3 531 535 1:STN:280:DyaK2c7lt1GmtA%3D%3D 8109491
27. MP Federle PJ Chang S Confer, et al. 1998 Frequency and effects of ionic and nonionic CT contrast media during rapid bolus injection Radiology 206 3 637 640 1:STN:280:DyaK1c7lsFGrsQ%3D%3D 9494479
28. JE Jacobs BA Birnbaum CP Langlotz 1998 Contrast media reactions and extravasation: relationship to intravenous injection rates Radiology 209 2 411 416 1:STN:280:DyaK1M%2FisVKquw%3D%3D 9807567
29. CL Wang RH Cohan JH Ellis, et al. 2007 Frequency, management, and outcome of extravasation of nonionic iodinated contrast medium in 69, 657 intravenous injections Radiology 243 1 80 87 10.1148/radiol.2431060554 17392249
30. JJ Caro E Trindade M McGregor 1991 The risks of death and of severe nonfatal reactions with high- vs low-osmolality contrast media: a meta-analysis AJR Am J Roentgenol 156 4 825 832 1:STN:280:DyaK3M7msFOntA%3D%3D 1825900
31. WH Bush DP Swanson 1991 Acute reactions to intravascular contrast media: types, risk factors, recognition, and specific treatment AJR Am J Roentgenol 157 6 1153 1161 1:STN:280:DyaK38%2FlvVCmsw%3D%3D 1950858
32. JR Dillman PJ Strouse JH Ellis, et al. 2007 Incidence and severity of acute allergic-like reactions to i.v nonionic iodinated contrast material in children AJR Am J Roentgenol 188 6 1643 1647 10.2214/AJR.06.1328 17515388
33. H Katayama K Yamaguchi T Kozuka, et al. 1990 Adverse reactions to ionic and nonionic contrast media. A report from the Japanese Committee on the Safety of Contrast Media Radiology 175 3 621 628 1:STN:280:DyaK3c3mtVWkuw%3D%3D 2343107
34. ST Cochran K Bomyea JW Sayre 2001 Trends in adverse events after IV administration of contrast media AJR Am J Roentgenol 176 6 1385 1388 1:STN:280:DC%2BD3M3ovF2mug%3D%3D 11373197
35. CL Wang RH Cohan JH Ellis, et al. 2008 Frequency, outcome, and appropriateness of treatment of nonionic iodinated contrast media reactions AJR Am J Roentgenol 191 2 409 415 10.2214/AJR.07.3421 18647910
36. KL Nelson LM Gifford C Lauber-Huber, et al. 1995 Clinical safety of gadopentetate dimeglumine Radiology 196 2 439 443 1:STN:280:DyaK2MzktlWjuw%3D%3D 7617858
37. CU Herborn E Honold M Wolf, et al. 2007 Clinical safety and diagnostic value of the gadolinium chelate gadoterate meglumine (Gd-DOTA) Invest Radiol 42 1 58 62 1:CAS:528:DC%2BD2sXpslWgug%3D%3D 10.1097/01.rli.0000248893.01067.e5 17213750
38. AG Bleicher E Kanal 2008 Assessment of adverse reaction rates to a newly approved MRI contrast agent: review of 23,553 administrations of gadobenate dimeglumine Am J Roentgenol 191 6 W307 W311 10.2214/AJR.07.3951
39. C Christiansen WJ Pichler T Skotland 2000 Delayed allergy-like reactions to X-ray contrast media: mechanistic considerations Eur Radiol 10 12 1965 1975 1:STN:280:DC%2BD3Mvptlylsg%3D%3D 10.1007/s003300000543 11305580
40. RO Berkseth CM Kjellstrand 1984 Radiologic contrast-induced nephropathy Med Clin North Am 68 2 351 370 1:STN:280:DyaL2c7ms1Kksw%3D%3D 6423916
41. C Cruz H Hricak F Samhouri, et al. 1986 Contrast media for angiography: effect on renal function Radiology 158 1 109 112 1:STN:280: DyaL28%2FmvV2itw%3D%3D 3079623
42. DW Cockcroft MH Gault 1976 Prediction of creatinine clearance from serum creatinine Nephron 16 1 31 41 1:STN:280:DyaE28%2FnsF2isw%3D%3D 10.1159/000180580 1244564
43. T Hafez 2007 Modification of diet in renal disease (MDRD) estimated glomerular filtration rate (eGFR) formula Am J Cardiol 99 4 584 10.1016/j.amjcard.2006.10.013 17293208
44. R Solomon C Werner D Mann, et al. 1994 Effects of saline, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents N Engl J Med 331 21 1416 1420 1:STN:280:DyaK2M%2FlvFahuw%3D%3D 10.1056/NEJM199411243312104 7969280
45. RJ Solomon MK Natarajan S Doucet, et al. 2007 Cardiac angiography in renally impaired patients (CARE) study: a randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease Circulation 115 25 3189 3196 10.1161/CIRCULATIONAHA.106.671644 17562951
46. CS Baker A Wragg S Kumar, et al. 2003 A rapid protocol for the prevention of contrast-induced renal dysfunction: the RAPPID study J Am Coll Cardiol 41 12 2114 2118 10.1016/S0735-1097(03)00487-X 12821233
47. F Ferrario MT Barone G Landoni, et al. 2009 Acetylcysteine and non-ionic isosmolar contrast-induced nephropathy-a randomized controlled study Nephrol Dial Transpl 24 10 3103 3107 1:CAS:528:DC%2BD1MXhtFygsL%2FP 10.1093/ndt/gfp306
48. MZ Kanter 2006 Comparison of oral and i.v. acetylcysteine in the treatment of acetaminophen poisoning Am J Health Syst Pharm 63 19 1821 1827 1:CAS:528:DC%2BD28XhtFSju73O 10.2146/ajhp060050 16990628
49. MJ Schweiger CE Chambers CJ Davidson, et al. 2007 Prevention of contrast induced nephropathy: recommendations for the high risk patient undergoing cardiovascular procedures Catheter Cardiovasc Interv 69 1 135 140 10.1002/ccd.20964 17139671
50. CM Younathan JV Kaude MD Cook, et al. 1994 Dialysis is not indicated immediately after administration of nonionic contrast agents in patients with end-stage renal disease treated with maintenance dialysis AJR Am J Roentgenol 163 4 969 971 1:STN:280:DyaK2cznvV2htQ%3D%3D 8092045
51. Manufactuer's Briefing Documents for FDA AdCom Meeting Dec (2009) http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/ Drugs/AnestheticAndLifeSupportDrugsAdvisoryCommittee/UCM183205.pdf
52. T Grobner 2006 Gadolinium-a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? Nephrol Dial Transpl 21 4 1104 1108 1:CAS:528:DC%2BD28XivVOntb8%3D 10.1093/ndt/gfk062
53. MA Perazella 2009 Current status of gadolinium toxicity in patients with kidney disease Clin J Am Soc Nephrol 4 2 461 469 1:CAS:528:DC%2BD1MXjslagurk%3D 10.2215/CJN.06011108 19201920
54. P Marckmann L Skov K Rossen, et al. 2006 Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging J Am Soc Nephrol 17 9 2359 2362 10.1681/ASN.2006060601 16885403
55. MR Prince H Zhang M Morris, et al. 2008 Incidence of nephrogenic systemic fibrosis at two large medical centers Radiology 248 3 807 816 10.1148/radiol.2483071863 18710976